 |
|
|
|
|
|
|
|
 |
Results for 'Johnson & Johnson' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Johnson & Johnson Vision Care, Inc. Medical Equipment Company Share Analysis
|
July 2008 |
£650 |
100 % |
Johnson & Johnson Healthcare - Medical Equipment SWOT Report
|
August 2008 |
£44 |
99 % |
Johnson & Johnson Medical Device Company Intelligence Report
|
December 2007 |
£695 |
99 % |
PharmaVitae 2005: Johnson & Johnson Global Analysis
|
July 2005 |
£2005 |
98 % |
Johnson & Johnson -Deals & Alliances Report
|
February 2008 |
£300 |
96 % |
Johnson & Johnson -Detailed Product Pipeline
|
February 2008 |
£375 |
96 % |
Johnson Johnson Partnering Guide 2008
|
July 2021 |
£195 |
96 % |
Johnson & Johnson IMS Company Profile
|
February 2007 |
£510 |
96 % |
Johnson & Johnson -Financial Company Report
|
February 2008 |
£175 |
96 % |
Johnson & Johnson: PharmaVitae Profile
PharmaVitae Profile
|
March 2007 |
£3010 |
93 % |
Johnson & Johnson Inc: OTC Healthcare
|
October 2007 |
£195 |
93 % |
Johnson & Johnson -Therapeutic Competitors
|
February 2008 |
£175 |
93 % |
Johnson & Johnson Prospects to 2010
|
June 2007 |
£595 |
93 % |
Johnson & Johnson - SWOT Analysis
|
June 2008 |
£66 |
93 % |
Spotlight Report Series: Deal Making Spotlight on Johnson & Johnson
|
April 2006 |
£350 |
90 % |
Johnson Matthey PLC - SWOT Analysis
|
February 2008 |
£66 |
66 % |
Johnson & Johnson
PharmaVitae Profile
|
July 2008 |
£3010 |
38.5 % |
UK Pharmaceutical Products Market Development Report
|
September 2001 |
£600 |
38 % |
Risperidone: Pipeline™ Selector
Patent Report
|
Ongoing |
£210 |
37.5 % |
China Medical Devices Market Report
2007
|
July 2007 |
£240 |
36 % |
Risperidone: Pipeline™ Developer
Patent Report
|
Ongoing |
£1825 |
35 % |
Johnson & Johnson Deals
Partneringdesk briefing
|
July 2005 |
£215 |
35 % |
Implantable Medical Devices to 2009
|
December 2005 |
£2740 |
34 % |
Chemicals Sensors to 2008
Liquid, Gas & Biosensors
|
March 2004 |
£2540 |
34 % |
Watson
Pharmavitae Generics Profile
|
September 2007 |
£2005 |
33.5 % |
Cosmeceuticals to 2008
|
November 2004 |
£2670 |
33 % |
Diabetes Monitoring Products & Therapies to 2008
|
February 2005 |
£2670 |
32.5 % |
Cardiovascular Catherers and Systems
|
January 2007 |
£2510 |
32 % |
Oncology Market Forecast to 2013
|
July 2008 |
£10625 |
32 % |
In Vitro Diagnostics to 2009
Demand and Sales Forecasts, Market Share, Market Size, Market Leaders
|
April 2007 |
£2935 |
31.5 % |
The Future of Monoclonal Antibodies Therapeutics
Innovation in antibody engineering, key growth strategies and forecasts to 2011
|
July 2006 |
£1495 |
30.5 % |
Centocor, Inc. - SWOT Analysis
|
October 2008 |
£66 |
30 % |
ALZA Corporation - SWOT Analysis
|
May 2007 |
£66 |
29.5 % |
Partnering And Business Trends In Transgenic Manufacturing
|
January 2004 |
£95 |
29 % |
Hologic Medical Device Company Intelligence Report
|
January 2006 |
£295 |
28.5 % |
MorphoSys Ag
Premium Company Profile
|
April 2008 |
£265 |
28.5 % |
Crisis Management And Corporate Reputation
Counter-Generics Strategy, Tactics and Execution
|
November 2007 |
£4560 |
28.5 % |
Medicated Skin Care in India
|
February 2008 |
£450 |
28 % |
Accelerate M&A Success
Making Integration Work
|
December 2007 |
£4560 |
27.5 % |
Corporate Security
Protecting Productivity
|
December 2007 |
£4560 |
27.5 % |
Boston Scientific Medical Device Company Intelligence Report
|
October 2006 |
£395 |
27.5 % |
Combating Generics 2008
Counter-Generics Strategy, Tactics and Execution
|
December 2007 |
£5015 |
27.5 % |
Johnson & Johnson
Strategic Analysis Profile
|
February 2008 |
£515 |
27.3 % |
Johnson & Johnson Inc
|
February 2006 |
£195 |
27.3 % |
Monoclonal Antibodies Report Part II
Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff
|
September 2007 |
£3800 |
27 % |
Educating the Market: Creating Value Through Support of Continuing Medical Education
|
March 2008 |
£2260 |
26.5 % |
Anti Infectives, Vol II: Antibacterials
|
April 2007 |
£1950 |
25 % |
Commercial Insight: Cytotoxic Therapy Cancer Brands
Looming Patent Expiries Limit Market Growth
|
July 2008 |
£7600 |
25 % |
Therapeutic Proteins
|
February 2005 |
£1999 |
24.5 % |
Building Pharmaceutical-Biotechnology Partnerships and Alliances
Market Preparation & Strategic Support
|
October 2007 |
£4560 |
24.5 % |
Commercial and Pipeline Insight: Opioids
Short Acting and Anti-Abuse Technologies Set to Fragment and Grow The Market
|
March 2008 |
£7600 |
24.5 % |
Commercial Insight: Antibacterials
Pharma Strikes Antibac
|
August 2005 |
£8000 |
24.5 % |
Johnson & Johnson Inc: OTC Healthcare
|
January 2007 |
£195 |
24.15 % |
Ethicon Medical Device Company Intelligence Report
|
December 2007 |
£295 |
23 % |
Rewarding & Recognizing Top-Performing Sales People
|
March 2008 |
£2260 |
23 % |
Commercial Insight: Pain Market Overview
Non-Traditional Analgesics and Opioid Reformulations to Sustain Sector Growth
|
October 2008 |
£8000 |
23 % |
Malaysia Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
23 % |
Pharmaceutical Regulatory Affairs in The Eu & US
|
January 2006 |
£1095 |
22.5 % |
Infusion Pumps Worldwide
A Market Strategy Report
|
July 2006 |
£1300 |
22 % |
Global Health Care Equipment
Health Care Equipment
|
May 2008 |
£180 |
21.7 % |
OTC Pharmaceuticals in China
|
December 2007 |
£125 |
21.35 % |
Pharma R&D Fact Book, The
2006
|
November 2007 |
£595 |
21 % |
Spotlight Report Series: Deal Making Spotlight on GlaxoSmithKline
|
April 2006 |
£350 |
21 % |
Spotlight Report Series: Deal Making Spotlight on Pfizer
|
April 2006 |
£350 |
21 % |
Spotlight Report Series: Deal Making Spotlight on Sanofi-Aventis
|
April 2006 |
£350 |
21 % |
Global Health Care Supplies
Health Care Supplies
|
May 2008 |
£180 |
21 % |
Spotlight Report Series: Deal Making Spotlight on Novartis
|
April 2006 |
£350 |
21 % |
Global Health Care Equipment & Supplies
|
July 2008 |
£180 |
20.65 % |
Global Pharmaceuticals
|
December 2007 |
£125 |
20.65 % |
World OTC Pharmaceutical Markets
Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends
|
May 2008 |
£2085 |
20.5 % |
Health Care Equipment & Supplies in Europe
|
July 2008 |
£180 |
20.3 % |
World Generics Market 2006-2011; The
|
May 2006 |
£1499 |
20 % |
Ethicon Endo-Surgery Medical Device Company Intelligence Report
|
December 2007 |
£295 |
20 % |
Pharmaceuticals in Canada
|
December 2007 |
£125 |
19.95 % |
Health Care Equipment & Supplies in Canada
|
July 2008 |
£180 |
19.95 % |
Pharmaceuticals in the United States
|
December 2007 |
£125 |
19.6 % |
Health Care Equipment & Supplies in the United States
|
July 2008 |
£180 |
19.6 % |
World Wound Care Markets 2008
Sales and Key Trends in The Treatment of Burns, Skin Ulcers, Surgical and Trauma Wounds
|
May 2008 |
£1825 |
19.5 % |
Leukemia - A Therapeutic & Competitive Insight
|
October 2006 |
£1660 |
19.5 % |
Competitive Outlook on Apoptosis in Oncology
|
December 2006 |
£1660 |
19.5 % |
Health Care Equipment & Supplies in France
|
July 2008 |
£180 |
19.25 % |
World Market for In Vitro Diagnostics 2005; The
|
January 2005 |
£1299 |
19 % |
Global Protein Therapeutics Market Analysis
|
September 2007 |
£1175 |
19 % |
Health Care Equipment & Supplies in the United Kingdom
|
July 2008 |
£180 |
18.9 % |
Pharmaceutical Parallel Trade in the United Kingdom, 2000-2006
Market Insights and Trends in a Primary Import Destination
|
August 2006 |
£900 |
18.5 % |
Eisai Prospects to 2110
Pipeline Products Performance Potential
|
October 2007 |
£595 |
18.5 % |
The CNS Market Outlook to 2011
|
November 2006 |
£1495 |
18.5 % |
Prostate and Breast Cancer- New Treatments & Developmental Progress
|
March 2007 |
£2510 |
18.5 % |
CNS Market Outlook to 2011, The
|
November 2006 |
£1495 |
18.5 % |
Development and Commercialisation of Protein Therapeutics
Technologies, pipelines and forecasts
|
September 2004 |
£1045 |
18.5 % |
Partneringreview 2006
|
February 2006 |
£2195 |
18.5 % |
World Market for Sexual Disorders, 2005-2012, The
Traversing New Frontiers in Sexual Chemistry
|
January 2006 |
£1900 |
18 % |
Product Lifecycle Management, 2006
|
May 2006 |
£1499 |
18 % |
Merck & Co Inc Deals
Partneringdesk briefing
|
July 2005 |
£215 |
18 % |
Licensing Agreement in Pharmaceutical Business Development, The
3rd Edition
|
July 2007 |
£492 |
18 % |
The Licensing Agreement in Pharmaceutical Business Development
3rd edition
|
July 2007 |
£450 |
18 % |
Eisai Pipeline - Products - Performance - Potential
|
June 2008 |
£595 |
17.5 % |
World Neurodegeneratives Disease Markets
|
February 2005 |
£1499 |
17.5 % |
Partneringreview 2006 - Company Deal Index
Volume 1
|
February 2006 |
£1395 |
17.5 % |
Partneringreview 2006 – Financings
Volume 3
|
February 2006 |
£1395 |
17.5 % |
Partneringreview 2006 – Deal Type
Volume 5
|
February 2006 |
£1395 |
17.5 % |
Breast Cancer
The Latest R&D Trends
|
February 2007 |
£1660 |
17.5 % |
Partneringreview 2006 – Stage of Development
Volume 4
|
February 2006 |
£1395 |
17.5 % |
Partneringreview 2006 – Industry Sector
Volume 6
|
February 2006 |
£1395 |
17.5 % |
Partneringreview 2006 – Therapy Area
Volume 2
|
February 2006 |
£1395 |
17 % |
Medical Device Companies Performance Tables 2006
|
September 2006 |
£395 |
17 % |
Cordis Medical Device Company Intelligence Report
|
November 2007 |
£295 |
17 % |
The Medical Device Industry Report 2007
|
October 2007 |
£495 |
16.5 % |
Datascope Medical Device Company Intelligence Report
|
December 2006 |
£395 |
16 % |
Drug Delivery Technology: Revolutionizing Cardiovascular Therapies
|
July 2007 |
£945 |
16 % |
Comprehensive Analysis of R&D and Commercialization
for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100
|
February 2007 |
£715 |
16 % |
Anti Addiction Therapies, 2006-2011- The Pharmaceutical Industry's Next Viagra?
|
October 2006 |
£1499 |
15.5 % |
Multiple Myeloma - Exploring New Targets For Multiple Drug Therapy
Stakeholder Opinions
|
December 2007 |
£2005 |
15.4 % |
Ion Channel Drug Discovery
Therapeutic Opportunities & Technology Progress
|
May 2004 |
£850 |
15 % |
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists
Competitor Analysis
|
November 2008 |
£210 |
14.7 % |
Global Pharmaceuticals & Biotechnology
|
May 2005 |
£105 |
14.7 % |
Psychopharmacotherapy Market Insights
Obstacles & Opportunities in Mood Disorders & Cognitive Impairment, 2005-2012
|
November 2005 |
£1900 |
14 % |
Hematological Cancers - A Therapeutic & Competitive Insight
|
October 2006 |
£2510 |
14 % |
Bigpharma Agreements Handbook
Partnering Agreements
|
September 2001 |
£2195 |
14 % |
Bigpharma Partnering Agreements
|
March 2001 |
£1195 |
14 % |
Global Pharmaceuticals - Yearly Update 2006
|
July 2007 |
£600 |
13.65 % |
Analgesics in France
|
July 2008 |
£450 |
13.3 % |
Digestive Remedies in Finland
|
June 2008 |
£450 |
13.3 % |
Stem Cells - The hype and the hope
Business opportunities and forecasts
|
January 2007 |
£4999 |
13.3 % |
Eye Care in France
|
July 2008 |
£450 |
13.3 % |
Wound Treatments in France
|
July 2008 |
£450 |
13.3 % |
Global Orthopedics
|
September 2008 |
£180 |
13.3 % |
UK Pharmaceutical Executive Pay
Insight into Director Remuneration
|
March 2005 |
£25 |
13 % |
Digestive Remedies in Germany
|
July 2008 |
£450 |
12.95 % |
Orthopedics in Europe
|
September 2008 |
£180 |
12.95 % |
NRT Smoking Cessation Aids in Germany
|
July 2008 |
£450 |
12.95 % |
Analgesics in Germany
|
July 2008 |
£450 |
12.95 % |
Orthopedics in Asia-Pacific
|
September 2008 |
£180 |
12.95 % |
Vitamins And Dietary Supplements in France
|
July 2008 |
£450 |
12.95 % |
Eye Care in Germany
|
July 2008 |
£450 |
12.95 % |
Medicated Skin Care in Germany
|
July 2008 |
£450 |
12.95 % |
NRT Smoking Cessation Aids in France
|
July 2008 |
£450 |
12.95 % |
Wound Treatments in Germany
|
July 2008 |
£450 |
12.95 % |
Medicated Skin Care in France
|
July 2008 |
£450 |
12.95 % |
Orthopedics in the United Kingdom
|
September 2008 |
£180 |
12.6 % |
Orthopedics in Japan
|
September 2008 |
£180 |
12.6 % |
Vitamins And Dietary Supplements in Germany
|
July 2008 |
£450 |
12.6 % |
Orthopedics in Germany
|
September 2008 |
£180 |
12.6 % |
Wound Treatment in the United Kingdom
|
December 2005 |
£450 |
12.25 % |
Orthopedics in France
|
September 2008 |
£180 |
12.25 % |
Analgesics in the UK
|
March 2006 |
£450 |
12.25 % |
Cough, Cold And Allergy (Hay Fever) Remedies in Germany
|
July 2008 |
£450 |
12.25 % |
Orthopedics in the United States
|
September 2008 |
£180 |
12.25 % |
Cough, Cold And Allergy (Hay Fever) Remedies in France
|
July 2008 |
£450 |
12.25 % |
How to React to Parallel Trade
|
January 2007 |
£1095 |
12 % |
Smoking Cessation Aids in the United Kingdom
|
December 2005 |
£450 |
11.9 % |
Eye Care in Denmark
|
December 2007 |
£450 |
11.9 % |
Business Blogging for Pharma
|
August 2007 |
£2005 |
11.9 % |
Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam
|
January 2008 |
£450 |
11.9 % |
Digestive Remedies in China
|
September 2007 |
£450 |
11.9 % |
UK Medical Equipment Market Development Report
|
August 2001 |
£600 |
11.9 % |
Wound Treatments in Spain
|
July 2006 |
£450 |
11.9 % |
Digestive Remedies in Australia
|
November 2007 |
£450 |
11.9 % |
Digestive Remedies in Belgium
|
January 2008 |
£450 |
11.9 % |
Wound Treatments in the United Kingdom
|
August 2006 |
£450 |
11.9 % |
Eye Care in the United Kingdom
|
August 2006 |
£450 |
11.9 % |
Digestive Remedies in Brazil
|
August 2007 |
£450 |
11.9 % |
Eye Care in China
|
September 2007 |
£450 |
11.9 % |
Digestive Remedies in Canada
|
August 2007 |
£450 |
11.9 % |
UK Pharmaceutical Products
Market research report
|
September 2001 |
£600 |
11.55 % |
Digestive Remedies in Ireland
|
August 2007 |
£450 |
11.55 % |
Digestive Remedies in Japan
|
September 2007 |
£450 |
11.55 % |
Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape
|
August 2008 |
£3800 |
11.55 % |
Analgesics in Spain
|
July 2006 |
£450 |
11.55 % |
Digestive Remedies in Malaysia
|
December 2007 |
£450 |
11.55 % |
Digestive Remedies in the UK
|
March 2006 |
£450 |
11.55 % |
Pharmaceutical Companies Performance Tables 2005
|
November 2006 |
£295 |
11.55 % |
Medicated Skincare in the United Kingdom
|
December 2005 |
£450 |
11.55 % |
Eye Care in Australia
|
November 2007 |
£450 |
11.55 % |
Vitamins And Dietary Supplements in the UK
|
March 2006 |
£450 |
11.55 % |
Smoking Cessation Aids in Germany
|
November 2005 |
£450 |
11.55 % |
Digestive Remedies in the United Kingdom
|
August 2007 |
£450 |
11.55 % |
Digestive Remedies in Vietnam
|
January 2008 |
£450 |
11.55 % |
Analgesics in the United Kingdom
|
August 2006 |
£450 |
11.55 % |
Medicated Skin Care in the UK
|
March 2006 |
£450 |
11.55 % |
NRT Smoking Cessation Aids in the United Kingdom
|
August 2006 |
£450 |
11.55 % |
Eye Care in United States
|
May 2006 |
£450 |
11.55 % |
Eye Care in Spain
|
July 2006 |
£450 |
11.55 % |
Digestive Remedies in the Czech Republic
|
November 2007 |
£450 |
11.55 % |
Analytical R&D Tool - Analysis of Prostate Cancer R&D
The Complete Guide
|
February 2004 |
£3400 |
11.5 % |
Digestive Remedies in the United Kingdom
|
August 2006 |
£450 |
11.2 % |
Digestive Remedies in Mexico
|
February 2008 |
£450 |
11.2 % |
NRT Smoking Cessation Aids in Spain
|
July 2006 |
£450 |
11.2 % |
Digestive Remedies in Spain
|
July 2006 |
£450 |
11.2 % |
Eye Care in Argentina
|
August 2007 |
£450 |
11.2 % |
Digestive Remedies in Argentina
|
August 2007 |
£450 |
11.2 % |
Digestive Remedies in United States
|
May 2006 |
£450 |
11.2 % |
Smoking Cessation Aids in France
|
January 2006 |
£450 |
11.2 % |
Vitamins and Dietary Supplements in Spain
|
July 2006 |
£450 |
11.2 % |
Digestive Remedies in New Zealand
|
January 2008 |
£450 |
11.2 % |
Medicated Skin Care in Spain
|
July 2006 |
£450 |
11.2 % |
Medicated Skin Care in the United Kingdom
|
August 2006 |
£450 |
11.2 % |
NRT Smoking Cessation Aids in United States
|
May 2006 |
£450 |
11.2 % |
Eye Care in Brazil
|
August 2007 |
£450 |
11.2 % |
Vitamins and Dietary Supplements in the United Kingdom
|
August 2006 |
£450 |
11.2 % |
Digestive Remedies in Venezuela
|
February 2008 |
£450 |
11.2 % |
Bristol-Myers Squibb Company Deals
Partneringdesk briefing
|
July 2005 |
£215 |
11 % |
Vitamins And Dietary Supplements in United States
|
May 2006 |
£450 |
10.85 % |
Study # 2255: Implantable Medical Devices
New Industry Forecasts For 2011 & 2016
|
October 2007 |
£1455 |
10.85 % |
Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom
|
August 2006 |
£450 |
10.85 % |
Cough, Cold and Allergy (Hayfever) Remedies in the United Kingdom
|
December 2005 |
£450 |
10.85 % |
Cough, Cold and Allergy (Hay Fever) Remedies in Spain
|
July 2006 |
£450 |
10.85 % |
Cough, Cold And Allergy (Hay Fever) Remedies in the UK
|
March 2006 |
£450 |
10.85 % |
Dircetory of Clinical Research Companies in India
|
January 2008 |
£600 |
10.85 % |
World Pharmaceutical Market (2007)
|
November 2006 |
£485 |
10.85 % |
Medicated Skin Care in United States
|
May 2006 |
£450 |
10.85 % |
New Drug Futures: Anti-Infective Chapter
|
May 2006 |
£695 |
10.85 % |
Digestive Remedies in Norway
|
October 2007 |
£450 |
10.85 % |
Global Market for Hormonal Contraceptives and Infertility Drugs, 2005-2012; The
|
January 2006 |
£1900 |
10.5 % |
Digestive Remedies in Italy
|
September 2007 |
£450 |
10.5 % |
Lebanon Pharmaceuticals and Healthcare Report Q3 2007
|
September 2007 |
£360 |
10.5 % |
Cough, Cold And Allergy (Hay Fever) Remedies in United States
|
May 2006 |
£450 |
10.5 % |
Medical & Dental Adhesives & Sealants
US industry forecasts to 2011 & 2016
|
May 2007 |
£2870 |
10.5 % |
CNS Market Trends, 2007 to 2010
Key Market Forecasts and Growth Opportunities
|
June 2007 |
£995 |
10.15 % |
Facts and Trends in Deal Making
A Perspective on the Pharma & Biotech Industries
|
February 2005 |
£595 |
10.15 % |
Wound Treatments in Italy
|
September 2006 |
£450 |
10.15 % |
|
|
